GRAIL Stock Quote GRAL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

14.22

Bid

13.93

Ask

14.40

Volume

682,935

13.83 Day's Range 14.28

12.56 52 Week Range 21.47

Market Cap

441.519M

Previous Close

13.55

Open

13.86

Last Trade

14.2

Last Trade Time

Financial Volume

$ 9,599,261

VWAP

14.0559

Average Volume (3m)

1,475,199

Shares Outstanding

31,049,148

Dividend Yield

PE Ratio

-0.30

Earnings Per Share (EPS)

-47.21

Revenue

93.11M

Net Profit

-1.47B

GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

grail.com

Headquarters

Wilmington, Delaware, USA

Founded

GRAIL Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker GRAL. The last closing price for GRAIL was $13.55. Over the last year, GRAIL shares have traded in a share price range of $ 12.56 to $ 21.47.

GRAIL currently has 31,049,148 shares outstanding. The market capitalization of GRAIL is $420.72 million. GRAIL has a price to earnings ratio (PE ratio) of -0.30.

Nvidia Subpoenaed by DOJ, Athira Pharma Shares Plunge 71% After Study Fails, Zscaler Falls 15% Post-Earnings

Nvidia (NASDAQ:NVDA) – Nvidia’s stock closed down 9.5% on Tuesday, leading to a $279 billion loss in market value due to fading optimism over AI following weak economic data...

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) PR Newswire MENLO PARK, Calif., Aug. 30, 2024 MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL...

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology PR Newswire MENLO PARK, Calif., Aug. 29, 2024 Data Support Clinical...

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif., Aug. 21, 2024 MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc...

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update PR Newswire MENLO PARK, Calif., Aug. 13, 2024 Second Quarter Revenue Grew 43% Year-Over-Year to $32.0...

Wheels Up Announces Gregory Summe to Join Board of Directors

Wheels Up Announces Gregory Summe to Join Board of Directors PR Newswire ATLANTA, Aug. 8, 2024 Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom ATLANTA, Aug...

GRAIL to Announce Second Quarter 2024 Financial Results

GRAIL to Announce Second Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., July 31, 2024 MENLO PARK, Calif., July 31, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population PR Newswire MENLO PARK...

GRAIL Advances the Galleri® Registrational Clinical Trial Program

GRAIL Advances the Galleri® Registrational Clinical Trial Program PR Newswire MENLO PARK, Calif., July 15, 2024 GRAIL Completes Enrollment of More Than 35,000 Participants in the PATHFINDER 2...

Nike Stock Drops 14% in Pre-Market; Nokia Acquires Infinera for $2.3 Billion, and More News

Nike (NYSE:NKE) – Nike shares fell 14.04% in pre-market trading. Nike exceeded fourth-quarter fiscal earnings estimates with adjusted earnings of $1.01 per share, but sales of $12.6 billion...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.73	-10.8463949843	15.95	17.49	12.56	952909	14.36884011	CS
4	-4.41	-23.6714975845	18.63	21.47	12.56	1475199	15.86157637	CS
12	-4.41	-23.6714975845	18.63	21.47	12.56	1475199	15.86157637	CS
26	-4.41	-23.6714975845	18.63	21.47	12.56	1475199	15.86157637	CS
52	-4.41	-23.6714975845	18.63	21.47	12.56	1475199	15.86157637	CS
156	-4.41	-23.6714975845	18.63	21.47	12.56	1475199	15.86157637	CS
260	0	0	0	14.28	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	225.83M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	168.56M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	131.85M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	122.46M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	119.52M